Oruka Therapeutics announced that it will receive $275 million in a round of funding on April 3, 2024. The transaction included participation from syndicate of healthcare investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.865 USD | +3.90% | +12.10% | +122.35% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+122.35% | 53.97M | |
+6.68% | 113B | |
+10.97% | 106B | |
+0.87% | 22.27B | |
-12.58% | 22.22B | |
-5.57% | 19.43B | |
-37.85% | 17.87B | |
-6.41% | 17.24B | |
+7.57% | 14.29B | |
+34.56% | 12.52B |
- Stock Market
- Equities
- ABIO Stock
- News ARCA biopharma, Inc.
- Oruka Therapeutics announced that it expects to receive $275 million in funding